A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
for Ovarian Cancer
Sites in Charlotte +12 more locations
Sponsor: Compugen Ltd
Sex: Female·Age: 18+
Code: NCT06888921·Phase 1, Phase 2·Recruiting·Listed Mar 2025